Santen Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 390,000 | 0.113% |
Public Companies | 6,204,000 | 1.79% |
General Public | 147,449,179 | 42.6% |
Institutions | 192,302,360 | 55.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
19,140,800 | US$206.8m | 0% | 0.07% | |||
18,733,186 | US$202.4m | 0% | 0.04% | |||
18,290,500 | US$197.6m | 0% | 0.76% | |||
13,738,444 | US$148.4m | -34.1% | 1.99% | |||
11,338,800 | US$122.5m | 0% | 0.08% | |||
10,973,101 | US$118.6m | -0.55% | no data | |||
10,662,000 | US$115.2m | 0% | 0.13% | |||
10,314,615 | US$111.4m | 1.78% | 0.14% | |||
9,041,567 | US$97.7m | 0% | 0.01% | |||
8,202,700 | US$88.6m | 0% | 0.03% | |||
6,988,717 | US$75.5m | -50% | 0.37% | |||
6,863,000 | US$74.1m | 0% | no data | |||
6,380,965 | US$68.9m | 2.34% | no data | |||
6,204,000 | US$67.0m | 0% | no data | |||
5,289,300 | US$57.1m | 4.97% | 0.04% | |||
2,568,536 | US$27.8m | -0.09% | no data | |||
2,485,770 | US$26.9m | 0% | 0.01% | |||
2,236,700 | US$24.2m | -1.19% | 0.01% | |||
1,952,001 | US$21.1m | -0.09% | no data | |||
1,787,900 | US$19.3m | 0% | 0.38% | |||
1,748,700 | US$18.9m | 0% | 0.02% | |||
1,728,116 | US$18.7m | 0.3% | no data | |||
1,412,500 | US$15.3m | 0% | 0.16% | |||
1,316,495 | US$14.2m | 0% | 0.01% | |||
1,300,513 | US$14.1m | 0.56% | 0.01% |